Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Three Part, First-in-human, Randomized, Double-masked, Placebo-Controlled, Safety, Tolerability and Early Efficacy Study of MGV354 in Healthy Subjects and in Patients With Ocular Hypertension or Glaucoma

NCT02743780 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT02743780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02743780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Three Part, First-in-human, Randomized, Double-masked, Placebo-Controlled, Safety, Tolerability and Early Efficacy Study of MGV354 in Healthy Subjects and in Patients With Ocular Hypertension or Glaucoma
Lead sponsor
Alcon Research
Phase
Phase 1/2
Overall status
Completed
Start date
March 2, 2016
Completion date
September 20, 2016
Enrollment
191 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open-angle glaucoma